Sionna's surprise cystic fibrosis trial failure sinks hopes of challenging Vertex
Sionna Therapeutics’ bid to become the next cystic fibrosis drug developer after Vertex Pharmaceuticals has taken a major hit, after Sionna reported that its lead asset failed an early study and ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Sionna cystic fibrosis drug fails key trial, removing threat to Vertex biopharmadive.com
